Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
145 Cards in this Set
- Front
- Back
what are two biogenic amines
|
epinepherine
norepinephrine |
|
what are the binding properties of receptors
|
saturability
affinity specificity |
|
what is Ka equal to
|
1/Kd (association constant)
|
|
is a specific binding curve able to be to show saturablilty
|
yes
|
|
is a non specific binding curve able to show saturabiliy
|
no
|
|
what is a scatcher plot
|
enable us to plot binding ina linear form to get the total # of binding site/the dissassocition constant
|
|
In a scatcher plot what corresponds to the Y and X intercepts
|
Y=bound/free (hormones)
X=Bmax (R+RL) |
|
what are 5 ways that signal transmission is accompilished
|
gene activation
opening of ion channels by linked receptr enzymatic activity ligand-stimulated autophosporylation activation of a specific G protein |
|
how does a gated ion channel work
|
opens or closes in response to intracellular or extracellular signal ligand concentration or membrane potential
|
|
what is an example of a receptor enzyme
|
protein tyrosine kinase
|
|
how does receptor enzymes work
|
ligand binds to the extracellular domain and stimulates intracellular enzymatic activity
|
|
what is the general process of how a serpentine receptor works
|
ligand binds receptor
receptor activates intracellular GTP-binding protein (G) G regulates and enzyme that generates second messengers |
|
what are 3 ways that desensitization is accomplished
|
1. reduction in receptor #
2. localization of receptors at the cell sur 3. efficiency of the signal transmission generally all specific for agonists |
|
what is adaptation
|
the ability of signal systems to adjust to response to different levels of signals
|
|
how does an agonist inhibit a signal response
|
by blocking the binding of the agonist
|
|
T or F receptor activation triggers a feedback circuit that shuts off the receptor or removes it from the cell surface
|
T
|
|
T or F signal amplification is and aspect of signaling systems
|
T
|
|
what is integration (cross talk)
|
signals can oppose each other or reinforce each other. this can take place at multiple steps
|
|
what are four ways that ion channels are regulated
|
ligand gated channels
voltage-gated channels mechanically gated channels covanlent modification |
|
what causes cystic fibrosis
|
the CL- channels have been mutated which affect the ability of them to be regulated by covalent modification
|
|
what type of transport is involved in channels
|
passive transport.
all the regulation of the channels disscussed work by passive diffusion down their electrochemical gradients |
|
what ions does acetylcholine dependent gated protein allow
|
Ca+, Na+ or K+
|
|
in acetylcholine-dependent opening of gated proteins what happens when acetylcholine binds
|
a rotation of bound alpha helices to place polar aspect in the interior of the protein to facilitate Ca+, Na+ or K+
|
|
what is tertodotoxin
|
a neuro toxin that targets ion channels from japanese puffer fish
targets voltage-gated Na+channels |
|
what is saxitoxin
|
a neuro toxin that targets ion channels
from red tide targets voltage-gated Na+ channels |
|
what is Alpha-bungarotoxin
|
a neuro toxin that targets ion channels
venom from a banded krait snake that inhibits the nicotinic acetylcholine receptor |
|
dendrotoxin
|
a neuro toxin that targets ion channels from mamba snakes that block neuronal voltage dependent K+ channels
|
|
what do spider venom toxins inhibit
|
calcium channels or sodium potassium channels
|
|
what are conotoxins
|
a neuro toxin that targets ion channels from cone snails, most selective of all inhibitors, can select for voltage sensitive sodium, calcium or potassium channels and ligand-gated channels
these are being studied as starting materials for new drugs |
|
what are three channel specific drugs
|
local anesthetics, anticonvulsants, and antiarrhythmics
|
|
what is the most common type of enzyme activity found intrinsic to a transmembrane receptor
|
Protein Tyrosine Kinase
|
|
what types of signaling use PTK's
|
growth factors
insulin cytokines (interferons and interleukins) |
|
are receptors for PTK's single pass transmembrane proteins or multiple pass
|
single pass with ligand binding domain in the extracellular surface
|
|
what is unusual about the insulin receptor binding and protein tyrosine kinases domains
|
once the insulin ligand binds two dimers (heterodimers) for a tetrameric complex via disulfide bonds
|
|
what a kinase insert region
|
an important site for autophosphorylation and protein-protein interacitons
|
|
in receptor tyrosine kinases where are the aminoterminal and carboxytermial domains located
|
aminoterminal=extracellular
carboxyterminal=intracellular |
|
what type of site is created by autophosphorylation
|
phosphotyrosine site for binding of the SH2 protein
|
|
autophosphorylation can take place in two spots what are they
|
cytoplamic domain (growth factors/insulin)
the PTK receptor (cytokine receptor) |
|
what differs among effector proteins
|
the differ in the the SH2 structure which effect which specific tyrosine phosphate sites it reacts with
|
|
recruitment of effector proteins propogates the GF signal by which two ways
|
1. facillatating the binding of the effector protein to the its binding partner
2. facilitating phosphorylation of tyrosine with its accompanied activation of PTK |
|
what two hormones regulate cell proliferation
|
insulin
growth factor |
|
what is a Ras protein
|
a monomeric guanyl nuclotide-binding protein (G-protein) that activate the MAP kinase cascade which changes gene expression
|
|
in the major proliferative response involves what protein
|
the ras protein
|
|
what is SOS
|
a guanine-nucleotide exchange factor for Ras (in ras this stimulate the exchange of GDP for GTP (active))
|
|
between what two proteins does phosporylated tyrosine bind
|
Grb2 and SH2
|
|
what is the most common type of enzyme activity found intrinsic to a transmembrane receptor
|
Protein Tyrosine Kinase
|
|
what types of signaling use PTK's
|
growth factors
insulin cytokines (interferons and interleukins) |
|
are receptors for PTK's single pass transmembrane proteins or multiple pass
|
single pass with ligand binding domain in the extracellular surface
|
|
what is unusual about the insulin receptor binding and protein tyrosine kinases domains
|
once the insulin ligand binds two dimers (heterodimers) for a tetrameric complex via disulfide bonds
|
|
what a kinase insert region
|
an important site for autophosphorylation and protein-protein interacitons
|
|
in receptor tyrosine kinases where are the aminoterminal and carboxytermial domains located
|
aminoterminal=extracellular
carboxyterminal=intracellular |
|
what type of site is created by autophosphorylation
|
phosphotyrosine site for binding of the SH2 protein
|
|
autophosphorylation can take place in two spots what are they
|
cytoplamic domain (growth factors/insulin)
the PTK receptor (cytokine receptor) |
|
what differs among effector proteins
|
the differ in the the SH2 structure which effect which specific tyrosine phosphate sites it reacts with
|
|
recruitment of effector proteins propogates the GF signal by which two ways
|
1. facillatating the binding of the effector protein to the its binding partner
2. facilitating phosphorylation of tyrosine with its accompanied activation of PTK |
|
what two hormones regulate cell proliferation
|
insulin
growth factor |
|
what is a Ras protein
|
a monomeric guanyl nuclotide-binding protein (G-protein) that activate the MAP kinase cascade which changes gene expression
|
|
in the major proliferative response involves what protein
|
the ras protein
|
|
what is SOS
|
a guanine-nucleotide exchange factor for Ras (in ras this stimulate the exchange of GDP for GTP (active))
|
|
between what two proteins does phosporylated tyrosine bind
|
Grb2 (and SH2 containing adaptor protein)
SOS |
|
what does and activated Ras do
|
it binds and activates Raf-1
Ser/Thr selective protein kinase |
|
what does Raf-1 do
|
it activates MEK
|
|
what does MEK do
|
it activates ERK
|
|
what does ERK do
|
it phosoporylates proteins such as important transcription factors like pp90(kinase that phosporylates S6)
|
|
how is Ras's function in cancer patients
|
highly mutated
|
|
how is phosphatidylinositol 3-kinase activated
2 ways |
growth factor receptors
IRS-1 |
|
what does PI3-K generate
|
3,4,5 phosphatidylinositol PIP3 from PIP2
|
|
what is a Plekstrin homology domain (PH domain0
|
a region of protein that binds phosphoinositides and Beta/gamma units of G proteins as well protein kinase C
|
|
where does PIP3 interact with proteins
|
the PH domain
|
|
what is attacked to the PIP3
|
PKB protein kinase B
|
|
what does PTEN do and one what molecule does it act
|
terminates the signaling pathway
acts on PIP3 to change it back to PIP |
|
what is central to insulins effects on metabolism
|
PI3/PKB pathway
|
|
what C is targeted by the PI-3K
|
C3
phosphorylation here changes PIP2 to PIP3 |
|
what does PDK-1 do
|
phosporylates the PKB that is attached to PIP3
|
|
does what does activated PKB activate
|
GSK3
phosporylated form is the inactive form the active form causes inhibition |
|
what does and activated Ras do
|
it binds and activates Raf-1
Ser/Thr selective protein kinase |
|
what does Raf-1 do
|
it activates MEK
|
|
what does MEK do
|
it activates ERK
|
|
what does ERK do
|
it phosoporylates proteins such as important transcription factors like pp90(kinase that phosporylates S6)
|
|
how is Ras's function in cancer patients
|
highly mutated
|
|
how is phosphatidylinositol 3-kinase activated
2 ways |
growth factor receptors
IRS-1 |
|
what does PI3-K generate
|
3,4,5 phosphatidylinositol PIP3 from PIP2
|
|
what is a Plekstrin homology domain (PH domain0
|
a region of protein that binds phosphoinositides and Beta/gamma units of G proteins as well protein kinase C
|
|
where does PIP3 interact with proteins
|
the PH domain
|
|
what is attacked to the PIP3
|
PKB protein kinase B
|
|
what does PTEN do and one what molecule does it act
|
terminates the signaling pathway
acts on PIP3 to change it back to PIP |
|
what is central to insulins effects on metabolism
|
PI3/PKB pathway
|
|
what C is targeted by the PI-3K
|
C3
phosphorylation here changes PIP2 to PIP3 |
|
what does PDK-1 do
|
phosporylates the PKB that is attached to PIP3
|
|
does what does activated PKB activate
|
GSK3
phosporylated form is the inactive form the active for phophorylates glycogens synthase to inactive form |
|
what does active GSK3 phosphorylate
|
Glycogen syntase
when this is phosphorylated it is inactive |
|
what molecule stimulates GLUT4 to the plasma membrane
|
PKB
|
|
what is herceptin
|
a monoclonal antibody against Her2
|
|
what is Her2 involved in
|
breast cancer
|
|
what is Gleevec
|
drug that selects against tyrosine kinases in leukemia patients and GI tumors
|
|
what two drugs have been approved for use in colon rectal cancers
|
Erbitux
Avastin |
|
how are JAK activated
|
by trans autophosphorylation
|
|
what happens when cytokines bind to receptors that have little cytoplamic domains
|
triggers a stepwise association with the subunits B1 and B2 to the receptor
|
|
what comes along with the Beta 1 and 2 subunits
|
JAK molecule
|
|
what does JAK do?
|
stimulates tyrosine phosphorylation of components of STAT transcription factors
|
|
what is STAT
|
transcription factors that JAK acts on, which are then translocated to the nucleus for gene regulation
|
|
what happens to STAT after phosphorylation but before it enters the nucleus
|
becomes dimerized
|
|
what does cholera toxin effect
|
the G protein
|
|
what does the G protein do
|
activates adenylyl cyclase
|
|
what does adenylyl cyclase do
|
catalyzes the reaction of ATP to Camp
|
|
what are the 3 fates of Camp
|
1. exported out of the cell
2. changed to 5'-AMP (cyclic amp phosphoidesterase) 3. changes PKA to an active form |
|
what does active PKA do
|
phosphorylates ser/threonine resisdues in many structure in the cell
|
|
what characterizes a G protein
|
the alpha subunit
|
|
what do methyl xanthines do
|
they inhibit cyclic amp phosphodiesterases
|
|
T or F the cyclic AMP response pathway is not reversable at all
|
F
reversable at all levels |
|
what is the purpose of having multiple steps in the cyclic AMp pathway
|
allows for amplification and cross talk with other pathways
|
|
what is the response to TSH
|
thyroid hormone synthesis and secretion
|
|
what is the response to ACTH
|
cortisol synthesis and secretion
|
|
what is the response to LH
|
progesterone secretion
|
|
what is the response to adrenaline in the muscle
|
glycogen breakdown
|
|
what is the response to adrenaline in the heart
|
increase in heart rate and force of contraction
|
|
what is the response to adrenaline, ACTH, glucagon, TSH in fat
|
triacylglyceride breakdown
|
|
what is the response to glucagon
|
glycogen breakdown
|
|
what is the response to PTH
|
bone resorption
|
|
what is the response to vasopression
|
water resorption
|
|
what does inderal and propranalol do
|
beta blockers (antagonist that prevent binding of adrenaline)
|
|
what are Beta blockers such as inderal and propranalol used for
|
treatment of hypertension, migraines and some cardiac problems
some performers use them for stage fright |
|
what has a higer affinity value for B-catecholamine receptor antagonist or agonists
|
antagonist is way higher
|
|
what stimulates the exchange of GDP for GTP in a G protein
|
binding of the ligand to the receptor
|
|
what happens to the trimeric G protein when GTP is bound
|
GTP causes a dissassociation of the A subunit
the A subunit bound with GTP is the active G protein |
|
what causes the hydrolyzation of GTP on the Alpha sub unit of the G protein
|
intrinsic GTPase of the Alpha subunit
|
|
what is the subunit that the cholera toxin targets in the G protein
|
the alpha subunit which specifically attacks the intrinsic GTPase so the signal stay on!
|
|
what happens in the intestines when cholera toxin has done its worst
|
Camp dependent activation of CL- channels leads to secretion of sodium and water
|
|
how does C-amp activate PKA
|
by disinhibition of the R subunits blocking the PKA binding sites
|
|
why does PKA have two sites for binding
|
two site will give a stepper response curve
|
|
what are some important agonist in the Phosphotidyllinositol turnover signaling pathway
|
acetylcholine
histamine vasopression angiotensin platlet-derived growth factor |
|
what activates the Phosphotidylinositol turnover signaling pathway
|
hormone receptor complex that activates phospholipase C
|
|
what does phospholipase C do
|
takes phosphotidlinositol 4,5 bisphosphate and adds H2o and separates them to yeild
diacylglycerol inositol 1,4,5-triphosphate |
|
what directly activates phospholipase C
|
activated G protein
activated growth factor receptor |
|
what activates protein kinase C
|
diacylglycerol
|
|
what causes a release of Ca+ from the ER in the turnover signaling pathway
|
inositol 1,4,5 triphosphate
|
|
after PLC cleaves off diacylglycerol and IP3 what is the destination of these two molecules
|
diacylglycerol=stays in the membrane
IP3= is soluble and head to the nucleus |
|
what further degrades diacylglycerol in the the turnover pathway
|
phospholipases A1/A2
|
|
what is an alternative to further degredation of diacylglycerol besides the Phospholipase A1/A2
|
conversion to phosphatidic acid by phosphorylation
|
|
what molecule is able to mimic diacylglycerol in the activation of protein kinase C
|
Phorbol ester tumor promoters
these are metabollically stable |
|
what bond does Phospholipase A1 cleave in phosphotidylinositol
|
the bond ester bond at carbon 1 right next to the fatty acid chain
|
|
what bond does Phospholipase A2 cleave in phosphotidylinositol
|
the bond ester bond at carbon 2 right next to the fatty acid chain
|
|
what bond does Phospholipase C cleave in phosphotidylinositol
|
the bond phosphodiester bond at carbon 3 right inbetween the O and P
|
|
what bond does Phospholipase D cleave
|
the bond in between the P and the O on the side of the head group
|
|
when C2 is esterified with arachidonic acid in phophatidylinositol the molecule becomes a precursor for what
|
Eicosanoids
|